Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
BRCA-P: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, International Phase III Study to Determine the Preventive Effect of Denosumab on Breast Cancer in Women carrying a BRCA1 Germline Mutation
ARM: AXILLARY REVERSE MAPPING ? A PROSPECTIVE TRIAL TO STUDY RATES OF LYMPHEDEMA AND REGIONAL RECURRENCE AFTER SENTINEL LYMPH NODE BIOPSY AND SENTINEL LYMPH NODE BIOPSY FOLLOWED BY AXILLARY LYMPH NODE DISSECTION WITH AND WITHOUT AXILLARY REVERSE MAPPING
Phase 1b Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Repeated Doses of DB-020 in Patients Receiving Cisplatin
Pilot Study of Effects of Bazedoxifene plus Conjugated Estrogen on Imaging and Blood Biomarkers In Women with Menopausal Symptoms at Increased Risk for Breast Cancer
Study Type: Prevention
Phase: Feasibility/Pilot
NCTID: NCT04821375
Principal Investigator:
Carol Fabian
The Effectiveness of Lactobacillus Plantarum LBP in Preventing Acute Graft-Versus-Host Disease GvHD in Children Undergoing Alternative Hematopoietic Progenitor Cell Transplantation HCT
Study Type: Prevention
Phase: III
NCTID: NCT03057054
Principal Investigator:
Keith August
Advancing Tobacco Use Treatment for African American Smokers
Study Type: Prevention
Phase: IV
NCTID: NCT02360631
Principal Investigator:
Lisa Cox
A Phase IB, Open-Label, Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of UTTR1147A in Combination with Standard of Care in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Effectiveness of the SpaceOAR Vue System in Subjects with Prostate Cancer being Treated with Stereotactic Body Radiotherapy SABRE
Study Type: Prevention
Phase: N/A
NCTID: NCT04905069
Principal Investigator:
Ronald Chen
The Role of Androgen Deprivation Therapy In CArdiovascular Disease ? A Longitudinal Prostate Cancer Study RADICAL PC1 and A RAndomizeD Intervention for CArdiovascular and Lifestyle Risk Factors in Prostate Cancer Patients RADICAL PC2
Study Type: Prevention
Phase: IV
NCTID: NCT03127631
Principal Investigator:
Charles Porter